The Anti-Obesity Treatment Wegovy Arrives in Tablets in French Pharmacies
26 Articles
26 Articles
So far only as an injection, Novo Nordisk's anti-obesity treatment, Wegovy, is available as a tablet in France this Monday. Who can be entitled to it, how much is it, how to take it and what competitors arrive?
This is the first medicine of the GLP-1 class marketed in France in oral form. These treatments imitate the action of an intestinal hormone that regulates appetite and promotes weight loss. Already available in the United States, the United Kingdom and Germany, the pill Wegovy (semaglutide), is offered in France on medical prescription to obese or overweight adults, with at least a co-morbidity related to their weight. At its launch, the tablet …
As of Monday, November 2, it is possible to obtain a tablet from the Wegovy pharmacy, provided that it has been prescribed by a doctor.
The drug Wegovy is now available as a pill in France, marking a new stage in the competition in the market for treatments against obesity L的anti-obesity Wegovy,
The medicine developed by Novo, previously administered by injection in France, is now available in oral form, while the Danish manufacturer and its American competitor, Eli Lilly, compete to win in a fast growing global market.
ledauphine.com
Four and a half months after the start of the reimbursement of the Mounjaro and Wegovy, two drug treatments against obesity, the waiting times in the specialist consultations authorized to prescribe them exploded. A parallel market also prospers, difficult to quantify. The tablet Wegovy arrives in pharmacy this Monday - a version not reimbursed.
Coverage Details
Bias Distribution
- 55% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
